The Food and Drug Administration (FDA) through the FDA Academy and the Center for Drug Regulation and Research (CDRR) conducted Training on CDRR Licensing and Registration Processes on 13-14 September 2023 at Vivere Hotel, Alabang, Muntinlupa City.
A total of sixty-three (63) participants from the pharmaceutical industry (manufacturers, traders, importers, and wholesalers), academe, and healthcare providers participated in the two-day training to enhance their regulatory knowledge on the submission of drug registration applications.
Several Subject Matter Experts (SMEs) from the CDRR served as resource persons discussing the licensing, pharmacovigilance, and registration of drug products for human use following the ASEAN Common Technical Requirements (ACTRs).
The first face-to-face training for CDRR’s stakeholders for this year aims to educate the participants to prepare and submit applications complying with the acceptable format by the review authorities to obtain early approval in the registration process. In line with the directive of DG Samuel Zacate, this learning activity endeavors to educate stakeholders with up-to-date regulations to enhance awareness and understanding of regulatory requirements and processes.
See more:-> https://bit.ly/3sOUgjF